Huada Gene is one of the largest gene sequencing companies in China, which was founded in 1999 and has gone through more than 20 years. In domestic and foreign markets, BGI has won wide recognition with its sufficient technical strength, comprehensive senior talent team, integrated medical industry resources, leading product and service standards, and continuous improvement and innovation of corporate culture. BGI has not only become a strategic partner of research institutions and large medical institutions at home and abroad, but also provided continuous basic support for undertaking major national scientific and technological projects, scientific research, disease prevention, medical diagnosis and other fields around the world.

BGI has made in-depth and meticulous exploration and professional development in the fields of high-precision sequencing, bioinformatics and clinical detection. At present, BGI's genetic testing business has been extended to many fields, such as preventive health care, family pedigree, tumor diagnosis, genetic diseases, stomatology, assisted reproduction and so on. Especially in the field of cancer, BGI has become the world's largest provider of personalized cancer genetic testing services, providing personalized and customized treatment programs for clinic. In addition, BGI's scientific research in the fields of biotechnology and biomedicine has made positive contributions to the construction of related disciplines and disease prevention in China.

For a long time, BGI has been constantly practicing innovation and creation, actively promoting the industrial application of genetic testing and medical innovation technology, and has embarked on a distinctive and advantageous development path. In the future, BGI will continue to tap the deep value in the field of life sciences, and strive to build an international pioneer enterprise with two-wheel drive of life science and technology innovation and industrialization.